Details for New Drug Application (NDA): 219557
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 219557
Tradename: | OLOPATADINE HYDROCHLORIDE |
Applicant: | Glenmark Pharms Inc |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 219557
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 219557
Suppliers and Packaging for NDA: 219557
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 219557 | ANDA | GLENMARK THERAPEUTICS INC., USA | 72657-194 | 72657-194-11 | 2 BOTTLE, PLASTIC in 1 CARTON (72657-194-11) / 2.5 mL in 1 BOTTLE, PLASTIC |
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 219557 | ANDA | GLENMARK THERAPEUTICS INC., USA | 72657-194 | 72657-194-25 | 1 BOTTLE, PLASTIC in 1 CARTON (72657-194-25) / 2.5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.2% BASE | ||||
Approval Date: | Feb 28, 2025 | TE: | RLD: | No |
Complete Access Available with Subscription